An evidence-aware, side-by-side comparison for U.S. shoppers — updated June 12, 2026.
Foundayo and JellyLean are not the same kind of product, and we won't pretend they are. Foundayo (orforglipron) is Eli Lilly’s once-daily oral GLP-1 receptor agonist, FDA-approved on April 1, 2026 for chronic weight management in adults with obesity or overweight with a weight-related condition. In its 72-week pivotal trial, average weight loss ranged from about 7.4% to 11.1% of body weight depending on dose. Self-pay pricing starts at $149/month for the lowest dose and reaches $349/month at the top doses ($299/month via Lilly’s Self-Pay Journey Program), while eligible insured patients may pay as little as $25/month. JellyLean, by contrast, is a $49 over-the-counter natural gummy that supports the body's own GLP-1 & GIP pathways — gradual, supplement-level support with no prescription required and a 60-day money-back guarantee. This page compares them honestly on cost, access, results, and safety so you can decide which route fits your situation.
| Criteria | JellyLean™ | Foundayo |
|---|---|---|
| Category | Dietary supplement (OTC) | FDA-approved prescription medication |
| Format | Daily gummy | Once-daily pill — no food or water restrictions |
| Core approach | Supports the body's own GLP-1 & GIP pathways | Pharmaceutical oral GLP-1 receptor agonist (orforglipron) |
| Formulation | Apple cider vinegar–based natural formula | Orforglipron — small-molecule GLP-1 receptor agonist; FDA-approved April 1, 2026 |
| Access | Over the counter — no prescription | Prescription only — pharmacies, LillyDirect, and telehealth platforms |
| Guarantee | 60-day money-back guarantee | No money-back guarantee (prescription medication) |
| Price | From $49/bottle (bundles lower per-bottle cost) | Self-pay from $149/month (0.8 mg) up to $349/month (top doses; $299 via Lilly’s Self-Pay program); insured patients from ~$25/month with savings card |
| Made by | USA, FDA-registered, GMP facility | Eli Lilly and Company (pharmaceutical) |
Body's own GLP-1 & GIP pathways · Gummy
ProsPharmaceutical oral GLP-1 receptor agonist (orforglipron) · Once-daily pill — no food or water restrictions
ProsJellyLean sits in the category of natural products designed to support the body's own GLP-1 response: acetic acid and botanicals that can slow stomach emptying, prolong fullness, and nudge the GLP-1/GIP satiety signals — real but modest biology. Foundayo (orforglipron) is Eli Lilly’s once-daily oral GLP-1 receptor agonist, FDA-approved on April 1, 2026 for chronic weight management in adults with obesity or overweight with a weight-related condition. In its 72-week pivotal trial, average weight loss ranged from about 7.4% to 11.1% of body weight depending on dose. Self-pay pricing starts at $149/month for the lowest dose and reaches $349/month at the top doses ($299/month via Lilly’s Self-Pay Journey Program), while eligible insured patients may pay as little as $25/month.
Important: no supplement, gummy, or botanical replicates prescription GLP-1 medication. Supplement benefits are supportive and gradual, alongside a balanced diet and activity. Results vary by individual.
JellyLean starts from $49 per bottle with multi-bottle bundles, a 60-day money-back guarantee, and U.S. shipping. Foundayo: Self-pay from $149/month (0.8 mg) up to $349/month (top doses; $299 via Lilly’s Self-Pay program); insured patients from ~$25/month with savings card. As a prescription medication it carries no money-back guarantee, and ongoing monthly cost continues for as long as treatment does.
This comparison is written for shoppers in the United States (pricing in USD). JellyLean ships within the U.S. from its official website; orders typically process in 2–3 days with delivery in roughly 5–7 business days. Foundayo availability: prescription only — pharmacies, lillydirect, and telehealth platforms.
This is a category comparison, not a level playing field. Foundayo is a clinically proven prescription medication: if you qualify medically and the monthly cost fits, it delivers weight loss a supplement cannot replicate — in a convenient daily pill. JellyLean is the no-prescription path: a $49 natural gummy supporting the body’s own GLP-1 and GIP pathways for gradual support, with a 60-day money-back guarantee and no pharmaceutical side-effect profile. Your eligibility, budget, and risk tolerance should drive the choice — and your doctor should be part of it.
Not in efficacy. Foundayo is an FDA-approved prescription GLP-1 pill that produced roughly 11% average body-weight loss at its top dose in 72-week trials. JellyLean is a natural supplement that supports the body’s own GLP-1/GIP pathways with gradual, supplement-level effects. They serve different situations — medical treatment versus over-the-counter support.
Foundayo self-pay starts at $149/month for the lowest dose and runs up to $349/month at the top doses; eligible insured patients may pay around $25/month. JellyLean starts at $49 per bottle with no prescription, membership, or refill requirements.
Foundayo requires a prescription from a licensed provider and meeting medical criteria (obesity, or overweight with a weight-related condition). JellyLean is an over-the-counter dietary supplement available to any adult.
Foundayo’s most common side effects include nausea, constipation, diarrhea, vomiting, indigestion, stomach pain, headache, and fatigue. JellyLean is a stimulant-free natural gummy that is generally well tolerated. Anyone with a medical condition or on medication should consult a healthcare provider before either option.